COPD: EPIDEMIOLOGY, RISK FACTORS, MELATONIN PARTICIPATION

It has been shown that at this stage it is not revealed a medicament for the treatment of COPD in the long term, can prevent decline in lung function that is the hallmark of this disease. Treatment of patients with COPD associated with some significant difficulties due to many factors: delays in seeking medical advice because scarce symptoms of the respiratory system progresses slowly over many years and persistent violations of irreversible bronchial obstruction. Due to the nature of endogenous melatonin, its antioxidant properties using this hormone can be an effective approach to the treatment of COPD.